Workflow
白花油(00239) - 2023 - 中期财报
PAK FAH YEOWPAK FAH YEOW(HK:00239)2023-09-15 08:30

Financial Performance - Revenue increased by 124.9% year-on-year to HKD 126,414,000 compared to HKD 56,202,000 in the same period last year[3][9] - The group's underlying recurring profit surged by 659.0% to HKD 59,054,000 from HKD 7,779,000 year-on-year[3][11] - Reported profit for the first half of 2023 was HKD 55,993,000, a significant turnaround from a loss of HKD 2,207,000 in the same period last year[4][10] - Earnings per share for reported profit was HKD 0.18, compared to a loss of HKD 0.007 per share in the previous year[10] - Total comprehensive income attributable to owners for the period was approximately HKD 71,899,000, compared to a loss of HKD 12,418,000 in the previous year[12] - The company reported a profit of HKD 2,750,000 in the financial investment segment, compared to a loss of HKD 4,110,000 in 2022[20] - The group recorded a net revaluation loss of HKD 5,293,000 for investment properties in the UK, compared to a loss of HKD 4,101,000 for the same period last year[31] - The operating profit for the period was HKD 68,297, compared to HKD 1,189 in the previous year, indicating a substantial improvement[47] - The group reported a profit of HKD 55,993 for the period, a significant recovery from a loss of HKD 2,207 in the same period last year[47] - The total comprehensive income attributable to the company's owners for the six months ended June 30, 2023, was HKD 71,899,000, compared to a loss of HKD 12,418,000 in the same period of 2022[103] Revenue Segmentation - The healthcare segment generated revenue of HKD 120,942,000, reflecting a 128.0% increase from the previous year's figures[9][11] - The property investment segment reported revenue of HKD 4,334,000, up 39.0% from the previous year[9][11] - The financial investment segment saw a dramatic increase in revenue to HKD 1,138,000, a rise of 3,824.1% year-on-year[9][11] - Healthcare segment revenue increased by 128.0% to HKD 120,942,000 compared to HKD 53,055,000 in 2022[13] - Profit from the healthcare segment surged by 296.7% to HKD 73,666,000 from HKD 18,571,000 in 2022[13] - Property investment revenue increased by 39.0% to HKD 4,334,000 from HKD 3,118,000 in 2022[16] - Income from financial investments surged by 3,824.1% to HKD 1,138,000 from HKD 29,000 in 2022[19] Market Performance - Sales in the Chinese market rose by 176.2%, driven by the reopening of cross-border travel and improved consumer sentiment[13] - Southeast Asia sales grew significantly, attributed to aggressive advertising campaigns in the Philippines and strong performance in Singapore[14] - The company expects continued sales momentum in the Chinese market for the remainder of the fiscal year[5] - The company anticipates continued sales momentum in the Chinese market for the remainder of the year, driven by strong local demand and a tight labor market in Hong Kong[88] Assets and Liabilities - The group’s total assets as of June 30, 2023, amounted to HKD 913,561, an increase from HKD 823,136 at the end of the previous year[43] - The group’s total liabilities were reported at HKD 115,911, compared to HKD 96,840 at the end of the previous year, indicating an increase in financial obligations[43] - The group’s total liabilities included bank borrowings due within one year amounting to HKD 5,488,000 as of June 30, 2023, slightly down from HKD 5,496,000 as of December 31, 2022[62] - The total accounts payable and other payables as of June 30, 2023, amounted to HKD 14,501,000, an increase from HKD 12,231,000 as of December 31, 2022[63] Cash Flow and Dividends - The net cash generated from operating activities for the six months ended June 30, 2023, was HKD 61,051,000, compared to HKD 8,685,000 in the same period of 2022[110] - The company paid dividends amounting to HKD 17,452,000 during the reporting period[109] - The company declared an interim dividend of HKD 0.03 per share and a special interim dividend of HKD 0.055 per share, totaling HKD 26,489,000, compared to HKD 7,168,000 in the previous year[70] - The company proposed a final dividend of HKD 0.038 per share, totaling HKD 11,842,000, and a special dividend of HKD 0.03 per share, totaling HKD 9,349,000, which was approved by shareholders on June 7, 2023[125] Employee and Operational Metrics - Employee costs increased by 9.3% to HKD 18,746,000 from HKD 17,158,000 in 2022[23] - The workforce increased to 99 employees as of June 30, 2023, up from 95 employees at the end of 2022, indicating growth in operational capacity[87] - New machinery will be purchased and installed to enhance production capacity in response to market demand[88] Financial Management - The group’s financial costs decreased slightly to HKD 434 from HKD 457 in the previous year, showing improved cost management[44] - Other operating expenses decreased by 17.6% to HKD 10,849,000 compared to HKD 13,166,000 in 2022, reflecting a lower percentage of total revenue at 8.6% versus 23.4% in 2022[54] - The company has maintained sufficient cash and marketable securities to meet its short-term liabilities and operational needs[83] Governance and Compliance - The company has adopted the corporate governance code as per the Hong Kong Stock Exchange rules and has complied with the code provisions during the reporting period, except for certain deviations[141] - The audit committee, composed of three independent non-executive directors, reviewed the interim financial information for the six months ended June 30, 2023[143] - The company has ensured that external auditors are present at the annual general meeting to address questions regarding audit work and independence, although unforeseen events prevented their attendance at the last meeting[142] - The company confirmed that all directors complied with the standards set out in the securities trading code during the reporting period[143]